<DOC>
	<DOC>NCT01010178</DOC>
	<brief_summary>Critical combination of various approved drugs in management for patients suffering with COPD.</brief_summary>
	<brief_title>Can Airflow Limitation in Chronic Obstructive Pulmonary Disease (COPD) be Reversible by Drugs?</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>current or past smoker COPD history of significant occupational or other environmental exposures or a connective tissue disease</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>86 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>COPD</keyword>
	<keyword>Macrolid</keyword>
	<keyword>reversibility</keyword>
	<keyword>Theophylline</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>symptoms PFT</keyword>
</DOC>